197 related articles for article (PubMed ID: 33028761)
21. Diagnostic utility of SOX11 immunohistochemistry in differentiating cutaneous spread of mantle cell lymphoma from primary cutaneous B-cell lymphomas.
Hsi AC; Hurley MY; Lee SJ; Rosman IS; Pang X; Gru A; Schaffer A
J Cutan Pathol; 2016 Apr; 43(4):354-61. PubMed ID: 26762898
[TBL] [Abstract][Full Text] [Related]
22. Identification of CD5/Cyclin D1 Double-negative Pleomorphic Mantle Cell Lymphoma: A Clinicopathologic, Genetic, and Gene Expression Study.
Chuang WY; Chang ST; Yuan CT; Chang GJ; Chang H; Yeh CJ; Ueng SH; Kao HW; Wang TH; Wan YL; Shih LY; Chuang SS; Hsueh C
Am J Surg Pathol; 2020 Feb; 44(2):232-240. PubMed ID: 31688139
[TBL] [Abstract][Full Text] [Related]
23. Composite follicular lymphoma and "early" (in situ and mantle zone growth pattern) mantle cell neoplasia: A rare entity with peculiar cytogenetic and clinical features.
Vivian LF; Magnoli F; Campiotti L; Chini C; Calabrese G; Sessa F; Tibiletti MG; Uccella S
Pathol Res Pract; 2020 Sep; 216(9):153067. PubMed ID: 32825940
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia.
Miranda RN; Briggs RC; Kinney MC; Veno PA; Hammer RD; Cousar JB
Mod Pathol; 2000 Dec; 13(12):1308-14. PubMed ID: 11144927
[TBL] [Abstract][Full Text] [Related]
25. SOX11, a key oncogenic factor in mantle cell lymphoma.
Beekman R; Amador V; Campo E
Curr Opin Hematol; 2018 Jul; 25(4):299-306. PubMed ID: 29738333
[TBL] [Abstract][Full Text] [Related]
26. Expression of sphingosine-1-phosphate receptor 1 in mantle cell lymphoma.
Nishimura H; Akiyama T; Monobe Y; Matsubara K; Igarashi Y; Abe M; Sugihara T; Sadahira Y
Mod Pathol; 2010 Mar; 23(3):439-49. PubMed ID: 20081804
[TBL] [Abstract][Full Text] [Related]
27. [Clinical and biological features and prognosis of patients with leukemic non-nodal mantle cell lymphoma].
Chen JW; Wang Y; Yan YT; Xiong WJ; Wang TY; Liu W; Zou DH; Qiu LG; Yi SH
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(23):1746-1752. PubMed ID: 37305933
[No Abstract] [Full Text] [Related]
28. In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.
Carvajal-Cuenca A; Sua LF; Silva NM; Pittaluga S; Royo C; Song JY; Sargent RL; Espinet B; Climent F; Jacobs SA; Delabie J; Naresh KN; Bagg A; Brousset P; Warnke RA; Serrano S; Harris NL; Swerdlow SH; Jaffe ES; Campo E
Haematologica; 2012 Feb; 97(2):270-8. PubMed ID: 22058203
[TBL] [Abstract][Full Text] [Related]
29. Transformation of indolent mantle cell lymphoma to pleomorphic mantle cell lymphoma: case report and review of clinical and morphologic variants.
Kiel MJ; Smith LB
Arch Pathol Lab Med; 2012 Aug; 136(8):871-5. PubMed ID: 22849733
[TBL] [Abstract][Full Text] [Related]
30. Mantle cell lymphoma with partial involvement of the mantle zone: an early infiltration pattern of mantle cell lymphoma?
Bassarova A; Tierens A; Lauritzsen GF; Fosså A; Delabie J
Virchows Arch; 2008 Oct; 453(4):407-11. PubMed ID: 18696109
[TBL] [Abstract][Full Text] [Related]
31. Lymphadenectomy Specimens in a Large Retrospective Cohort of Pediatric Patients Reveal No in situ Lymphomas but a Broad Spectrum of Reactive Changes.
Banz Y; Tzankov A; Dirnhofer S; Perren A; Hoeller S
Pathobiology; 2017; 84(3):139-143. PubMed ID: 27806371
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma.
Nygren L; Baumgartner Wennerholm S; Klimkowska M; Christensson B; Kimby E; Sander B
Blood; 2012 May; 119(18):4215-23. PubMed ID: 22431568
[TBL] [Abstract][Full Text] [Related]
33. Leukemic non-nodal cyclin D1- and SOX11-negative mantle cell lymphoma with CCND3::IGH rearrangement.
Tan L; Bansal G; Yeung CC; Yin J; Dave BJ; Konnick E; Wu D; Naresh KN
Ann Hematol; 2024 Feb; 103(2):667-669. PubMed ID: 37882866
[No Abstract] [Full Text] [Related]
34. Early lymph node involvement by mantle cell lymphoma limited to the germinal center: report of a case with a novel "follicular in situ" growth pattern.
Edlefsen KL; Greisman HA; Yi HS; Mantei KM; Fromm JR
Am J Clin Pathol; 2011 Aug; 136(2):276-81. PubMed ID: 21757601
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.
Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg Å; Christensson B; Sander B
Leuk Lymphoma; 2015 May; 56(5):1425-31. PubMed ID: 25120048
[TBL] [Abstract][Full Text] [Related]
36. [Right cervical lymph node enlargement].
Xie JL; Zhou XG; Wang ZQ
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):273-4. PubMed ID: 23928539
[No Abstract] [Full Text] [Related]
37. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
[TBL] [Abstract][Full Text] [Related]
38. In situ neoplasia in lymph node pathology.
Oishi N; Montes-Moreno S; Feldman AL
Semin Diagn Pathol; 2018 Jan; 35(1):76-83. PubMed ID: 29129357
[TBL] [Abstract][Full Text] [Related]
39. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype.
Ribera-Cortada I; Martinez D; Amador V; Royo C; Navarro A; Beà S; Gine E; de Leval L; Serrano S; Wotherspoon A; Colomer D; Martinez A; Campo E
Mod Pathol; 2015 Nov; 28(11):1435-47. PubMed ID: 26360498
[TBL] [Abstract][Full Text] [Related]
40. Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma.
Quesada AE; Hu S; Li S; Toruner GA; Wei Q; Loghavi S; Ok CY; Jain P; Thakral B; Nwogbo OV; Kim D; Iyer SP; You MJ; Medeiros LJ; Tang G
Hum Pathol; 2024 Feb; 144():71-76. PubMed ID: 38301962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
